Medigen Vaccine Biologics Market Cap

Medigen Vaccine Biologics has a market cap or net worth of 15.89 billion as of April 2, 2025. Its market cap has decreased by -19.39% in one year.

Market Cap

15.89B

Enterprise Value

14.32B

Revenue

605.64M

Ranking

n/a

PE Ratio

n/a

Stock Price

48.35

Market Cap Chart

Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 15.89B, an increase of 460.65%. That is a compound annual growth rate of 19.54%.

Market Cap History

Date	Market Cap	% Change
Apr 1, 2025	16.21B	36.75%
Dec 31, 2024	11.85B	-48.55%
Dec 29, 2023	23.04B	1.10%
Dec 30, 2022	22.78B	-64.20%
Dec 30, 2021	63.65B	192.75%
Dec 31, 2020	21.74B	388.97%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	178.51B
Caliway Biopharmaceuticals	113.99B
Bora Pharmaceuticals Co., LTD.	71.78B
Lotus Pharmaceutical	61.56B
Oneness Biotech	32.98B
Lumosa Therapeutics	29.22B
Pegavision	28.08B
Polaris Group	27.65B

Market Cap Rankings